Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
post-traumatic stress disorder (PTSD) children and adolescents SSRIs/SNRIs benzodiazepine use specific drugs used
Potential pharmacodynamic interactions with antiretrovirals
Practical application of tapering
Pregabalin generalised anxiety disorder in pregnancy use in patients with hepatic impairment in overdose use in opiate misusers
Potassium levels, psychotropic agent effects
power to treat, under S58 of the Mental Health Act
Pramipexole, bipolar depression
Pregnancy alcohol use depression/antidepressants gynaecological and obstetric haemorrhage risk newly diagnosed mental illness psychiatric illness as risk factor selective serotonin reuptake inhibitors tricyclic antidepressants benzodiazepines Drug choice in pregnancy in women taking psychotropic drugs planning when taking psychotropic drugs psychosis substance misuse
Pregnant women with mental illness Drug choice in pregnancy and psychotropic drugs
premenstrual syndrome (PMS) 474-475 hormonal treatment non-hormonal treatment medical menopause using gonadotrophin-releasing hormone agonists
Prescribers, duty of, medical conditions and safe driving
Prescribing in attention deficit hyperactivity disorder (ADHD)
Prescribing principles
Preterm delivery risks antipsychotics pimavanserin antidepressants lithium tricyclic antidepressants
Preventing sudden cessation by non-compliance
Prevention and management Clozapine-induced gastrointestinal hypomotility Clozapine: common adverse effects risk factors
Principles of prescribing
Pro-drugs, not recommended in hepatic impairment
Prolactin effects
Prolactin levels antipsychotic medication monitoring menopausal women antidepressant effects elevation psychotropic agent effects
prolonged-release medications, buprenorphine/methadone/Buvidal
Promethazine acutely disturbed or violent behaviour in schizophrenia in pregnancy breastfeeding not recommended for managing behavioural and psychological symptoms of dementia
Prophylaxis in bipolar disorder
Propranolol, for tardive dyskinesia
Proteinuria, renal impairment assessment
proton pump inhibitors (PPIs), safety in older patients/dementia
Pseudobulbar affect, multiple sclerosis
Pseudoparkinsonism (drug-induced parkinsonism) 34 Extrapyramidal symptoms Negative symptoms Relative adverse effects - a rough guide Blood pressure changes with antipsychotics First-generation antipsychotics - place in therapy Prescribing in human immunodeficiency virus (HIV) Valproate
Psychiatric adverse effects of non-psychotropics antiretroviral therapy drugs and effects Summary of psychiatric adverse effects of non-psychotropics differential diagnosis Naranjo scale
Psychodynamic interventions depression adherence psychosis